Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lemaitre Vascular (LMAT) Current Leases (2019 - 2025)

Lemaitre Vascular (LMAT) has disclosed Current Leases for 7 consecutive years, with $2.9 million as the latest value for Q4 2025.

  • On a quarterly basis, Current Leases rose 9.81% to $2.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.9 million, a 9.81% increase, with the full-year FY2025 number at $2.9 million, up 9.81% from a year prior.
  • Current Leases was $2.9 million for Q4 2025 at Lemaitre Vascular, up from $2.8 million in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $2.9 million in Q4 2025 to a low of $1.8 million in Q2 2022.
  • A 5-year average of $2.3 million and a median of $2.4 million in 2023 define the central range for Current Leases.
  • Peak YoY movement for Current Leases: decreased 8.19% in 2022, then soared 50.38% in 2023.
  • Lemaitre Vascular's Current Leases stood at $1.9 million in 2021, then rose by 0.86% to $1.9 million in 2022, then surged by 31.02% to $2.5 million in 2023, then grew by 8.5% to $2.7 million in 2024, then grew by 9.81% to $2.9 million in 2025.
  • Per Business Quant, the three most recent readings for LMAT's Current Leases are $2.9 million (Q4 2025), $2.8 million (Q3 2025), and $2.8 million (Q2 2025).